Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-blockers to prevent exacerbation of retinopathy of prematurity
IRCT20230526058300N1Phase 2Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of carvedilol in retinopathy of prematurity (ROP), sponsored by Alborz University of Medical Sciences. Started Dec 2023; status: completed.
02
Drugs
carvedilol
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on IRCT20230526058300N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230526058300N1.